Seven Indian Drugmakers Named In U.S. Lawsuit For Inflating Prices Of Generics
General views of drugs. (Photographer: Dhiraj Singh/Bloomberg)

Seven Indian Drugmakers Named In U.S. Lawsuit For Inflating Prices Of Generics

The Nifty Pharma Index fell the most in nearly 30 months yesterday led by Sun Pharmaceutical Industries Ltd. and Cadila Healthcare Ltd. over concerns that a U.S. lawsuit accused seven Indian drugma...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.